Mesenchymal stem cells derived from wharton's jelly and their potential for cardio-vascular tissue engineering

Open Tissue Engineering and Regenerative Medicine Journal

Volumn 4, Issue SPEC. ISSUE 1, 2011, Pages 64-71

  Semenov, O V ^a   Breymann, C ^b  

^a Swiss Transfusion SRC   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Mesenchymal stem cells; Tissue engineering; Wharton's jelly

Indexed keywords

5' NUCLEOTIDASE; ENDOGLIN; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; FUNCTIONAL ANATOMY; HUMAN; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONHUMAN; PHENOTYPIC PLASTICITY; PLACENTA FUNCTION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; TISSUE ENGINEERING; UMBILICAL CORD; AMNION FLUID; BONE MARROW; CARDIOVASCULAR SYSTEM; CELL TYPE; EMBRYO MEMBRANE; FETUS MEMBRANE; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; MULTIPOTENT STEM CELL; PERINATAL PERIOD; PHENOTYPE; PLACENTA; TOOTH PULP; WHARTON JELLY;

EID: 84855758545     PISSN: None     EISSN: 18750435     Source Type: Journal    
DOI: 10.2174/1875043501104010064     Document Type: Review

References (85)

1. Da Silva Meirelles L, Chagastelles PC, Nardi NB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 2006; 119: 2204-13.
2. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9: 641-50.
3. Da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008; 26: 2287-99.
4. Rastegar F, Shenaq D, Huang J, et al. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2: 67-80.
5. Friedenstein AJ, Deriglasova UF, Kulagina NN, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974; 2: 83-92.
6. Ma T. Mesenchymal stem cells: From bench to bedside. World J Stem Cells. 2010; 2: 13-17.
7. Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 2003; 5: 32-45.
8. Stagg J, Galipeau J. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb Exp Pharmacol 2007: 45-66.
9. Noel D, Djouad F, Bouffi C, Mrugala D, Jorgensen C. Multipotent mesenchymal stromal cells and immune tolerance. Leuk Lymphoma 2007; 48: 1283-9.
10. Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lombardi G, Dazzi F. Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 2007; 83: 71-6.
11. Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-506.
12. Hematti P. Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev 2008; 22: 262-73.
13. Zhang X, Jiao C, Zhao S. Role of mesenchymal stem cells in immunological rejection of organ transplantation. Stem Cell Rev 2009; 5: 402-9.
14. Marcus AJ, Woodbury D. Fetal stem cells from extra-embryonic tissues: Do not discard. J Cell Mol Med 2008; 12: 730-42.
15. Pappa KI, Anagnou NP. Novel sources of fetal stem cells: Where do they fit on the developmental continuum? Regen Med 2009; 4: 423-33.
16. Semenov OV, Koestenbauer S, Riegel M, et al. Multipotent mesenchymal stem cells from human placenta: Critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol 2010; 202: 191-3.
17. Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: A source of stem cells for tissue regeneration and repair? Placenta 2009; 30: 2-10.
18. Strakova Z, Livak M, Krezalek M, Ihnatovych I. Multipotent properties of myofibroblast cells derived from human placenta. Cell Tissue Res 2008; 332: 479-88.
19. Markov V, Kusumi K, Tadesse MG, et al. Identification of cord blood-derived mesenchymal stem/stromal cell populations with distinct growth kinetics, differentiation potentials, and gene expression profiles. Stem Cells Dev 2007; 16: 53-73.
20. De Coppi P, Bartsch G, Jr., Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-6.
21. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004; 19: 1450-6.
22. Gluckman E, Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 2005; 7: 219-27.
23. Rocha V, Locatelli F. Searching for alternative hematopoietic stem cell donors for pediatric patients. Bone Marrow Transplant 2008; 41: 207-14.
24. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-6.
25. Langer R, Vacanti JP, Vacanti CA, Atala A, Freed LE, Vunjak- Novakovic G. Tissue engineering: Biomedical applications. Tissue Eng 1995; 1: 151-61.
26. Gude NM, Roberts CT, Kalionis B, King RG. Growth and function of the normal human placenta. Thromb Res 2004; 114: 397-407.
27. Larsen WJ. Human embryology. Chirchill Livingstone, Philadelphia 2001.
28. th ed. 2006.
29. Huppertz B. The anatomy of the normal placenta. J Clin Pathol 2008; 61: 1296-302.
30. Kaufmann P. Basic morphology of the fetal and maternal circuits in the human placenta. Contrib Gynecol Obstet 1985; 13: 5-17.
31. Raio L, Ghezzi F, Di Naro E, et al. Sonographic measurement of the umbilical cord and fetal anthropometric parameters. Eur J Obstet Gynecol Reprod Biol 1999; 83: 131-5.
32. Di Naro E, Ghezzi F, Raio L, Franchi M, D'Addario V. Umbilical cord morphology and pregnancy outcome. Eur J Obstet Gynecol Reprod Biol 2001; 96: 150-7.
33. Sobolewski K, Bankowski E, Chyczewski L, Jaworski S. Collagen and glycosaminoglycans of wharton's jelly. Biol Neonate 1997; 71: 11-21.
34. Vizza E, Correr S, Goranova V, et al. The collagen skeleton of the human umbilical cord at term. A scanning electron microscopy study after 2n-naoh maceration. Reprod Fertil Dev 1996; 8: 885-94.
35. Kobayashi K, Kubota T, Aso T. Study on myofibroblast differentiation in the stromal cells of wharton's jelly: Expression and localization of alpha-smooth muscle actin. Early Hum Dev 1998; 51: 223-33.
36. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2007; 2: 481-5.
37. Murohara T. Cord blood-derived early outgrowth endothelial progenitor cells. Microvasc Res 2010; 79: 174-7.
38. Schiebler T, Kaufmann P. Reife plazenta. In: V B, Th S, F K, eds. Die plazenta des menschen. Stuttgart: Georg Thieme Verlag 1981: 51-94.
39. Thomas J. Introduction to human embryology. London 1968.
40. Wynn R. Principles of placentation and early human development. In: Gruenwald P, Ed. The placenta. London: MTP; 1975: 18-35.
41. Troyer DL, Weiss ML. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008; 26: 591-9.
42. Karahuseyinoglu S, Cinar O, Kilic E, et al. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 2007; 25: 319-31.
43. Nanaev AK, Kohnen G, Milovanov AP, Domogatsky SP, Kaufmann P. Stromal differentiation and architecture of the human umbilical cord. Placenta 1997; 18: 53-64.
44. Can A, Karahuseyinoglu S. Concise review: Human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007; 25: 2886-95.
45. La Rocca G, Anzalone R, Corrao S, et al. Isolation and characterization of oct-4+/hla-g+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem Cell Biol 2009; 131: 267-82.
46. Asakawa N, Shimizu T, Tsuda Y, et al. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Biomaterials 2010; 31: 3903-9.
47. Seshareddy K, Troyer D, Weiss ML. Method to isolate mesenchymal-like cells from wharton's jelly of umbilical cord. Methods Cell Biol 2008; 86: 101-19.
48. Solanki A, Kim JD, Lee KB. Nanotechnology for regenerative medicine: Nanomaterials for stem cell imaging. Nanomedicine (Lond) 2008; 3: 567-78.
49. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006; 8: 315-7.
50. Rojewski MT, Weber BM, Schrezenmeier H. Phenotypic characterization of mesenchymal stem cells from various tissues. Transfus Med Hemother 2008; 35: 168-84.
51. Anzalone R, Lo Iacono M, Loria T, et al. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: Extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev 2011; 7: 342-63.
52. Anzalone R, Lo Iacono M, Corrao S, et al. New emerging potentials for human wharton's jelly mesenchymal stem cells: Immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev 2010; 19: 423-38.
53. Mayer J. Uses of homograft conduits for right ventricle to pulmonary artery connections in the neonatal period. Semin Thorac Cardiovasc Surg 1995; 7.
54. Schoen FJ, Levy RJ. Tissue heart valves: Current challanges and future research perspectives. J Biomed Mater Res 1999; 47: 439-65.
55. Turner CG, Fauza DO. Fetal tissue engineering. Clin Perinatol 2009; 36: 473-88.
56. Zund G, Hoerstrup SP, Schoeberlein A, et al. Tissue engineering: A new approach in cardiovascular surgery; seeding of human fibroblasts followed by human endothelial cells on resorbable mesh. Eur J Cardiothorac Surg 1998; 13: 160-4.
57. Lehle K, Hoenicka M, Jacobs VR, Schmid FX, Birnbaum DE. Cryopreservation of human endothelial cells for vascular tissue engineering. Cryobiology 2005; 50: 154-61.
58. Schmidt D, Breymann C, Weber A, et al. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg 2004; 78: 2094-8.
59. Horstrup S, Kadner A, Breymann C. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thor Surg 2002; 74: 46-52.
60. Kadner A, Hoerstrup S, Tracy J, et al. Human umbilical cord cells: A new cell source for cardiovascular tissue engineering. Ann Thorac Surg 2002; 74: 1422-8.
61. Breymann C, Schmidt D, Hoerstrup SP. Umbilical cord cells as a source of cardiovascular tissue engineering. Stem Cell Rev 2006; 2: 87-92.
62. Kadner A, Zund G, Maurus C, et al. Human umbilical cord cells for cardiovascular tissue engineering: A comparative study. Eur J Cardiothorac Surg 2004; 25: 635-41.
63. Schmidt D, Mol A, Neuenschwander S, et al. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg 2005; 27: 795-800.
64. Schmidt D, Mol A, Breymann C, et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 2006; 114: 125-31
65. Schmidt D, Mol A, Odermatt B, et al. Engineering of biologically active living heart valve leaflets using human umbilical cordderived progenitor cells. Tissue Eng 2006; 12: 3223-32.
66. Shinoka T, Ma PX, Shum-Tim D, et al. Tissue engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996; 94 (9 Suppl): 164-8.
67. Penolazzi L, Tavanti E, Vecchiatini R, et al. Encapsulation of mesenchymal stem cells from wharton's jelly in alginate microbeads. Tissue Eng Part C Methods 2010; 16: 141-55.
68. Zimmermann U, Cramer, H, Jork, A, et al. Microencapsulationbased cell therapy, in biotechnology: Special processes. Wiley- VCH Verlag GmbH, Weinheim, Germany 2008; Volume 10.
69. Kenar H, Kose GT, Toner M, Kaplan DL, Hasirci V. A 3d aligned microfibrous myocardial tissue construct cultured under transient perfusion. Biomaterials 2011.
70. Parolini O, Alviano F, Bagnara GP, et al. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international workshop on placenta derived stem cells. Stem Cells 2008; 26: 300-11.
71. Castro-Malaspina H, Gay RE, Resnick G, et al. Characterization of human bone marrow fibroblast colony-forming cells (cfu-f) and their progeny. Blood 1980; 56: 289-301.
72. Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): Implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557-64.
73. Schmidt D, Hoerstrup SP. Tissue engineered heart valves based on human cells. Swiss Med Wkly 2007; 137 (Suppl 155): 80S-5S.
74. Schmidt D, Mol A, Kelm JM, Hoerstrup SP. In vitro heart valve tissue engineering. Methods Mol Med 2007; 140: 319-30.
75. Hoerstrup SP, Sodian R, Sperling JS, Vacanti JP, Mayer JE, Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng 2000; 6: 75-9.
76. Kelm JM, Lorber V, Snedeker JG, et al. A novel concept for scaffold-free vessel tissue engineering: Self-assembly of microtissue building blocks. J Biotechnol 2010; 148: 46-55.
77. Yang J, Yamato M, Shimizu T, et al. Reconstruction of functional tissues with cell sheet engineering. Biomaterials 2007; 28: 5033-43.
78. Guillaume-Gentil O, Semenov OV, Zisch AH, Zimmermann R, Voros J, Ehrbar M. Ph-controlled recovery of placenta-derived mesenchymal stem cell sheets. Biomaterials 2011; 32: 4376-84.
79. Semenov OV, Malek A, Bittermann AG, Voros J, Zisch AH. Engineered polyelectrolyte multilayer substrates for adhesion, proliferation, and differentiation of human mesenchymal stem cells. Tissue Eng Part A 2009; 15: 2977-90.
80. Engel E, Michiardi A, Navarro M, Lacroix D, Planell JA. Nanotechnology in regenerative medicine: The materials side. Trends Biotechnol 2008; 26: 39-47.
81. Cavallo C, Cuomo C, Fantini S, et al. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J Cell Biochem 2011; 112: 1418-30.
82. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41.
83. Nekanti U, Mohanty L, Venugopal P, Balasubramanian S, Totey S, Ta M. Optimization and scale-up of wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res 2010; 5: 244-54.
84. Nekanti U, Dastidar S, Venugopal P, Totey S, Ta M. Increased proliferation and analysis of differential gene expression in human wharton's jelly-derived mesenchymal stromal cells under hypoxia. Int J Biol Sci 2010; 6: 499-512.
85. Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M. Longterm expansion and pluripotent marker array analysis of wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev 2010; 19: 117-30.